Medipath

What Medipath does

Medipath is a French private network of independent pathology practices specializing in anatomical and cytological pathology, with a core focus on cancer screening and diagnosis. Founded in 1999 and headquartered in Fréjus, the company operates 50+ pathology centers across France staffed by 500+ collaborators, including 100+ molecular pathologists and 100+ physicians, processing approximately 1.5 million patient dossiers per year. Medipath participates in French government-organized cancer screening programs for breast, cervical, and colorectal cancer, and positions itself as the first clinical step in cancer patient care pathways.

The company's core technology stack is built on digital pathology: Medipath was the first worldwide user of SG300 high-performance slide scanners, enabling digitization of microscope slides for pathologist review, remote expertise, and AI-assisted diagnosis. AI capability is assembled through partnerships with multiple vendors — IBEX (prostate and breast), OWKIN (colorectal), PRIMAA (skin), VITADX (bladder), and HOLOGIC (cervical) — integrated into the diagnostic workflow rather than developed in-house. Service offerings include the One Day Diag program (24-hour diagnosis for breast and thyroid anomalies at partner expert centers), the M3P patient-pathologist consultation program (€60 per consultation, fully reimbursed for ALD patients), and the My Medipath Patient portal (launched March 2025) for online access to results, payments, and insurance tele-transmission.

Medipath's revenue model is primarily professional services: pathology diagnostic analysis billed to Assurance Maladie (Sécurité Sociale) under regulated tariffs, with supplementary reimbursement from private insurers. Patient-facing services (M3P, portal-driven administrative services) add a modest direct-revenue and engagement layer. The go-to-market combines a B2B sales-led motion (healthcare professional referrals, courier-based sample logistics, hospital partnerships) with limited direct-to-consumer elements (M3P consultations, Doctolib booking). The group is owned and operated by liberal pathologists with no disclosed external investors, no parent company, and no funding rounds on record.

Name

Medipath

Legal name

Medipath, société d'exercice libéral par action simplifiée

Website

https://medipath.fr

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

251–500 employees

Short description

Medipath is a French private network of 50+ pathology centers processing 1.5 million cancer diagnostic cases annually for patients, prescribing physicians, and government screening programs, augmented by digital pathology and third-party AI tools.

Ownership category

akta.pro rank

Product category

Pathology Diagnostics Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industries

Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD), Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE)

Keywords

• Pathology diagnostics
• Cancer screening
• Anatomical pathology
• Digital pathology
• Molecular pathology

Headquarters

HQ city

Fréjus

HQ country

France

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel

Revenue model

1. Pathology Analysis Services: Medipath provides anatomical and cytological pathology diagnostic services. Revenue is generated through medical analysis billing to national health insurance (Sécurité Sociale) and supplementary health insurance providers. The company handles sample collection, transport, analysis, medical validation, and report transmission.
2. M3P Patient Consultations: Direct patient consultations with pathologists for diagnosis explanation. The consultation fee is €60, with 100% coverage by national health insurance for patients with ALD (Affection Longue Durée). Third-party payment (tiers payant) is applicable.
3. Patient Portal Services: Online services including access to medical history, invoice viewing and payment, electronic transmission of care sheets to insurance, and retrieval of payment attestations through the My Medipath Patient platform.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

Medipath operates a nationwide network of 50+ pathology centers in France providing anatomical and cytological pathology diagnostic services for cancer detection and screening. The company processes 1.5 million pathology dossiers annually, leveraging digital pathology with SG300 slide scanners and AI-augmented diagnostic tools across multiple cancer types. Its portfolio includes core pathology analysis, the One Day Diag rapid 24-hour diagnosis program for breast and thyroid cancer, and the M3P direct patient-pathologist consultation service.

Product overview

Medipath is a network of independent pathology practices offering anatomical and cytological pathology diagnostic services for cancer detection and diagnosis across France. The portfolio includes core pathology services (handling 1.5 million cases annually), One Day Diag rapid diagnostic programs, M3P patient-pathologist consultation services, and digital pathology platforms. AI-powered diagnostic tools (IBEX, OWKIN, PRIMAA, VITADX, HOLOGIC) assist pathologists across prostate, breast, colorectal, skin, bladder, and cervical cancers. Patient-facing services include the My Medipath Patient Portal for accessing results and payments, while healthcare professionals use dedicated portals for sample management and result access.

Differentiator

Problem solved

Functional benefit

Brands

• My Medipath Patient: Patient portal platform providing access to medical history, online payment of invoices, and insurance tele-transmission.
• One Day Diag
• M3P (Médecin-Malin-Patient)

Products and services

• One Day Diag Same-day diagnostic service providing rapid diagnosis within 24 hours for breast and thyroid cancer abnormalities, offered to patients with clinical symptoms or radiological anomalies through expert partner healthcare centers.
• M3P (Moments de Méthode Pathologique) Direct consultation program enabling patients to meet with pathologists who present and explain digitized examination images, answer questions about pathology reports, and provide clarity on diagnoses. Priced at €60 per consultation with full coverage by French national health insurance for ALD patients.
• Digital Pathology Platform Digital pathology platform using SG300 high-performance slide scanners to digitize microscope slides, enabling augmented pathology review, remote expertise sharing, case sharing for training or diagnostic purposes, and integration with AI diagnostic tools.
• AI Diagnostic Tools Suite (IBEX, OWKIN, PRIMAA, VITADX, HOLOGIC) Integrated suite of AI-powered computer vision diagnostic tools assisting pathologists in cancer detection across multiple cancer types: prostate, breast, colorectal, skin, bladder, and cervical cancers.
• My Medipath Patient Portal Secure online platform for patients to access medical records, view and pay invoices, download payment attestations, electronically transmit care sheets to health insurance, and receive SMS/email notifications when results become available.
• Healthcare Professional Portal Secure online portal for healthcare professionals to access result servers, manage sample submissions via dedicated forms with configurable pickup frequencies, and coordinate patient care across the Medipath network.
• Organized Cancer Screening Services Diagnostic pathology services delivered as part of the French government-organized national cancer screening programs for breast cancer (women aged 50-74), cervical cancer (women aged 25-65), and colorectal cancer (men and women aged 50-74).
• Molecular Pathology Services Molecular pathology diagnostics and analysis services for cancer, supported by a network of 100+ molecular pathologists across the centers, providing expertise on molecular markers for diagnosis and treatment selection.

Quantifiable outcome

• 1.5 million dossiers (cases) processed per year across the network
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature8 records

Partnerships

Nine partnerships are on record, tiered core, major and minor.

• IBEXcoreTechnology or IntegrationAI diagnostic partnership for prostate and breast cancer detection. IBEX provides artificial intelligence technology integrated into Medipath's diagnostic workflow to enhance accuracy and efficiency of cancer detection.
• OWKINcoreTechnology or IntegrationAI diagnostic partnership for colorectal cancer. OWKIN provides machine learning and AI solutions for colorectal cancer analysis, integrated into Medipath's pathology services.
• PRIMAAcoreTechnology or IntegrationAI diagnostic partnership for skin cancer detection. PRIMAA provides artificial intelligence technology for analyzing skin lesions and detecting skin cancer.
• VITADXcoreTechnology or IntegrationAI diagnostic partnership for bladder cancer. VITADX provides specialized artificial intelligence solutions for bladder cancer diagnostic analysis.
• HOLOGICcoreTechnology or IntegrationAI diagnostic partnership for cervical cancer screening. HOLOGIC provides AI-powered systems for cervical cancer detection and screening integrated into Medipath's services.
• ICM Mougins (Institut Cancerologie Mougins)majorStrategic or Co-development PartnerPartner healthcare establishment in Provence-Alpes-Côte d'Azur region for the One Day Diag breast cancer rapid diagnosis program. ICM Mougins hosts the same-day diagnostic pathway in collaboration with Medipath.
• BioServeur – DedaluscoreTechnology or IntegrationTechnology subcontractor providing the results server infrastructure. Dedalus (through BioServeur) provides and maintains the medical results server used by Medipath for secure results delivery.
• Agence LafabminorImplementation/ SI/ Consulting PartnerWebsite development agency responsible for Medipath's internet site (medipath.fr).
• French Government and Assurance MaladiecoreStrategic or Co-development PartnerGovernment-backed organized cancer screening programs for breast, cervical, and colorectal cancer. The French government and national health insurance (Assurance Maladie) deploy screening programs, with Medipath participating as a diagnostic provider.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• Owkin: AI-for-pathology startup partnered with Medipath on colorectal cancer diagnostics; comparable as an AI-oncology platform whose direct-to-hospital distribution could overlap with Medipath's workflow.
• HalioDx (Veracyte): Oncology diagnostics company focused on tumor profiling and immune-based biomarker testing; comparable in the specialized anatomic pathology and oncology diagnostics niche.
• Eurofins Genoma (Eurofins Clinical Diagnostics France): Specialized genetics, molecular pathology, and clinical diagnostics provider; comparable in the molecular and specialty oncology diagnostics overlap with Medipath's molecular pathology services.

Broad incumbents

• Roche Diagnostics: Global IVD and digital pathology platform vendor (uPath) used by many pathology labs; comparable as an upstream technology incumbent whose digital pathology platform overlaps with Medipath's SG300-driven workflow.

Direct peers

• Biogroup: Major French medical laboratory network with broad geographic coverage; comparable as a multi-site private pathology/biology operator serving both patients and healthcare professionals.
• Cerba Healthcare: French-headquartered clinical and specialty pathology laboratory network serving hospitals and clinicians across Europe; directly comparable as a multi-site independent pathology group operating at national scale with similar customer mix.
• Inovie: One of the largest French private medical biology and pathology networks, operating hundreds of labs across France; directly comparable in scale, business model, and customer base.
• Centre de Pathologie de la Côte d'Azur / independent pathology groups: Regional independent pathology groups across France (e.g., centres concurrents en PACA); comparable as smaller, regional anatomic pathology practices competing for the same referrer and patient base.
• Unilabs: European clinical laboratory and diagnostics group with significant operations in France; comparable in offering clinical diagnostics and pathology services to patients and physicians at scale.
• Synlab: Pan-European medical diagnostics services provider with extensive pathology and laboratory operations; comparable as a large-scale clinical lab chain serving similar hospital and patient segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@Medipath-France
• LinkedInfr.linkedin.com/company/medipath-france
• Instagraminstagram.com/medipathfrance

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medipath